Dublin, Dec. 20, 2018 (GLOBE NEWSWIRE) -- The "Global Interventional Oncology Market - (By Therapy - Radiation Therapy, Particle Embolization & Ablation; By Region - North America, Europe & Asia Pacific) Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.
The report provides in-depth analysis of the current scenario, detailed market outlook of the global interventional oncology market with coverage on major market segments such as Radiation Therapy, Particle Embolization & Ablation.
Future forecasts of interventional oncology market overall and across various market segments have been provided in the report till 2024. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Interventional oncology is expected to become the fourth pillar of cancer care, with medical, surgical, and radiation oncology. It provides with minimally invasive treatment option while mitigating various associated risks.
The growth of the global interventional oncology market is propelled by rising oncology incidences, growing demand for minimally invasive therapeutics and increasing geriatric population. However, the market faces several challenges due to high treatment cost, associated risk and presence of alternative treatment options.
Key Vendors
- Boston Scientific Corporation
- Accuray Incorporated
- Medtronic PLC
- Terumo Corporation
- Merit Medical Systems Inc.
- BTG PLC
These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section.
Key Topics Covered
1. Executive Summary
2. Research Methodology
3. Interventional Oncology
3.1 Overview
3.2 Applications
3.3 Interventional Oncology Approaches
3.3.1 Diagnostic techniques
3.3.2 Ablation techniques
3.3.3 Embolisation techniques
3.3.4 Palliative techniques
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Segments
4.2.2 Market Share by Region
5. Market Segmentation
5.1 Radiation Therapy
5.1.1 Overview
5.1.2 Market Sizing (Actual & Forecasted)
5.2 Ablation
5.2.1 Overview
5.2.2 Market Sizing (Actual & Forecasted)
5.3 Particle Embolization
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)
5.3.3 Market Share by Type
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trends & Development
7.1.1 Advent of Personalized Interventional Oncology
7.1.2 Adoption of Artificial Intelligence
7.1.3 Irreversible Electroporation (NanoKnife) Ablation Technique
7.1.4 Adoption of Microwave Ablation (MWA)
7.2 Growth Drivers
7.2.1 Rising Oncology Incidences
7.2.2 Growing Demand for Minimally Invasive Therapeutics
7.2.3 Increasing Geriatric Population
7.3 Challenges
7.3.1 High Treatment Cost
7.3.2 Associated Risks
7.3.3 Alternative Treatment Options
8. Competitive Landscape
8.1 Financial Analysis
8.2 Market Share Analysis
9. Company Profiles
9.1 Boston Scientific Corporation
9.2 Accuray Incorporated
9.4 Medtronic PLC
9.5 Terumo Corporation
9.6 Merit Medical Systems Inc.
9.7 BTG PLC
For more information about this report visit https://www.researchandmarkets.com/research/578g53/global?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.